Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer - Bernhard, H; Neudorfer, J; Gebhard, K (Cancer immunology, immunotherapy CII, 2008)
et al